Study To Test the Safety and Efficacy of TVI-Brain-1 As A Treatment for Recurrent Grade IV Glioma
NCT01290692
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
14
Enrollment
INDUSTRY
Sponsor class
Conditions
Grade IV Glioma
Grade IV Astrocytoma
Glioblastoma Multiforme
Interventions
BIOLOGICAL:
TVI-Brain-1
Sponsor
TVAX Biomedical